CIS football: Notice of investigation
OTTAWA (CIS) - The University of Waterloo has informed CIS that a student-athlete in the sport of football is the subject of an investigation related to banned substances (steroids and growth hormone).
OTTAWA (CIS) - The University of Waterloo has informed Canadian
Interuniversity Sport that a student-athlete in the sport of
football is the subject of an investigation related to banned
substances (steroids and growth hormone). CIS is very concerned
about this situation and is monitoring it closely and working in
cooperation with the University of Waterloo and the Canadian Centre
for Ethics in Sport (CCES) to conduct additional testing on
student-athletes.
This supplemental testing will serve to signal that CIS and CCES
are unequivocally opposed to the use of banned substances, to
identify student-athletes who may be cheating, and to protect the
rights and reputation of student-athletes who have chosen to
compete drug-free.
CIS began its doping control program in 1990. Since that time there
have been 56 doping infractions out of over 5,800 tests
conducted.
CIS and its member institutions require that all student-athletes
participate annually in a student-athlete drug education
program.
“Hard work is the best way to achieve excellence however some
athletes choose to cheat,” said CIS Chief Executive Officer,
Marg McGregor. “CIS is determined to uphold the commitment to
clean sport and deter athletes from doping by working with CCES to
implement a rigorous testing and education program.”
Breakdown of doping infractions by CIS student-athletes since 1990
(56):
By gender:
Men 54
Women 2
By substance:
Steroid 24
Marijuana 15
Cocaine 4
Cocaine & Marijuana 3
Ephedrine 3
Refusal 2
Tamoxifen 1
Letrozole 1
Ephedrine & Marijuana 1
Pseudoephedrine 1
Admitted usage 1
By sport:
Football 45
Ice Hockey 4
Basketball 4
Field Hockey 1
Soccer 1
Volleyball 1
The CIS Doping Control policies can be found at the following
link:
http://english.cis-sic.ca/information/members_info/pdfs/pdf_bylaws_policies_procedures/14_Policy_90.10_Drug_Education_2009-10.pdf
-CIS-
